Jpmorgan Chase & CO Catalent, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Catalent, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,520,308 shares of CTLT stock, worth $96.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,520,308

Previous 1,320,881 15.1%

Holding current value

$96.5 Million

Previous $74.3 Million 23.98%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$56.16 - $60.96 $11.2 Million - $12.2 Million	199,427 Added 15.1%	1,520,308 $92.1 Million
Q2 2024 Aug 12, 2024	BUY	$53.58 - $57.02 $7.24 Million - $7.71 Million	135,169 Added 11.4%	1,320,881 $74.3 Million
Q1 2024 May 10, 2024	BUY	$42.56 - $59.82 $14 Million - $19.6 Million	328,057 Added 38.25%	1,185,712 $66.9 Million
Q4 2023 Feb 12, 2024	SELL	$32.18 - $46.57 $12.7 Million - $18.4 Million	-394,325 Reduced 31.5%	857,655 $38.5 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $1.64 Million - $1.86 Million	-37,138 Reduced 2.88%	1,251,980 $57 Million
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $4.82 Million - $10.2 Million	-151,365 Reduced 10.51%	1,289,118 $55.9 Million
Q1 2023 May 18, 2023	BUY	$45.44 - $74.26 $3.85 Million - $6.29 Million	84,744 Added 6.25%	1,440,483 $94.7 Million
Q1 2023 May 11, 2023	SELL	$45.44 - $74.26 $5.03 Million - $8.22 Million	-110,677 Reduced 7.55%	1,355,739 $89.1 Million
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $122 Million - $238 Million	-2,941,509 Reduced 66.73%	1,466,416 $66 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $32 Million - $50 Million	-441,711 Reduced 9.11%	4,407,925 $319 Million
Q2 2022 Aug 11, 2022	BUY	$87.2 - $114.05 $32.7 Million - $42.8 Million	375,217 Added 8.39%	4,849,636 $520 Million
Q1 2022 May 11, 2022	BUY	$94.19 - $124.49 $63.5 Million - $83.9 Million	673,706 Added 17.73%	4,474,419 $496 Million
Q4 2021 Feb 10, 2022	SELL	$119.57 - $139.07 $5.01 Million - $5.82 Million	-41,874 Reduced 1.09%	3,800,713 $487 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $419 Million - $547 Million	3,842,587 New	3,842,587 $511 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Catalent, Inc. Transaction History